Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-22-021828

Chief Financial Officer sold 282 shares at $29.87 ($8,423)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Catinazzo Thomas Chief Financial Officer 2022-03-29 Sale −282 $29.87 $8,423 53,977 D: show line 1 in the form
Open-market sales · 282 sh · avg $29.87 · $8,423
Loading xslF345X03/doc4.xml…